Non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatment

被引：1
作者：
Katsiki, Niki [1 ]
Athyros, Vasilios G. [2 ]
机构：
[1] AHEPA Univ Hosp, Dept Internal Med 1, Ctr Diabet Endocrinol & Metab, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Hippocrat Hosp, Med Sch, Propedeut Dept Internal Med 2, Thessaloniki, Greece
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2019年 / 35卷 / 07期
关键词：
FATTY LIVER-DISEASE; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR OUTCOMES; STATINS; RISK; BILIRUBIN; LIRAGLUTIDE;
D O I：
10.1080/03007995.2019.1589152
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1305 / 1306
页数：2
相关论文
共 50 条
  • [21] The Higher Prevalence of Non-Alcoholic versus Alcoholic Steatohepatitis in Alcoholics
    Gruszewska, Ewa
    Gudowska, Monika
    Wojtowicz, Ewa
    Cylwik, Bogdan
    Szmitkowski, Maciej
    Chrostek, Lech
    CLINICAL LABORATORY, 2015, 61 (11) : 1769 - 1774
  • [22] Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus
    Li, Wei-Dong
    Fu, Kun-Fa
    Li, Gui-Mei
    Lian, Yan-Shu
    Ren, Ai-Min
    Chen, Yun-Jue
    Xia, Jin-Rong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (32) : 9607 - 9613
  • [23] Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes
    Lembo, Erminia
    Russo, Maria Francesca
    Verrastro, Ornella
    Anello, Danila
    Angelini, Giulia
    Iaconelli, Amerigo
    Guidone, Caterina
    Stefanizzi, Gianluigi
    Ciccoritti, Luigi
    Greco, Francesco
    Sessa, Luca
    Riccardi, Laura
    Pompili, Maurizio
    Raffaelli, Marco
    Vecchio, Fabio Maria
    Bornstein, Stefan R.
    Mingrone, Geltrude
    Gastaldelli, Amalia
    Capristo, Esmeralda
    DIABETES & METABOLISM, 2022, 48 (05)
  • [24] Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease?
    Mazzotti, Arianna
    Caletti, Maria Turchese
    Marchignoli, Francesca
    Forlani, Giulia
    Marchesini, Giulio
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (03) : 235 - 240
  • [25] Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
    Zhu, Bo
    Chan, Siu-Lung
    Li, Jack
    Li, Kathryn
    Wu, Hao
    Cui, Kui
    Chen, Hong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [26] Future trends in the treatment of non-alcoholic steatohepatitis
    Fiorucci, Stefano
    Biagioli, Michele
    Distrutti, Eleonora
    PHARMACOLOGICAL RESEARCH, 2018, 134 : 289 - 298
  • [27] Nitrosamine Exposure Causes Insulin Resistance Diseases: Relevance to Type 2 Diabetes Mellitus, Non-Alcoholic Steatohepatitis, and Alzheimer's Disease
    Tong, Ming
    Neusner, Alexander
    Longato, Lisa
    Lawton, Margot
    Wands, Jack R.
    de la Monte, Suzanne M.
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (04) : 827 - 844
  • [28] Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
    Weinmann, Arndt
    Alt, Yvonne
    Koch, Sandra
    Nelles, Carina
    Dueber, Christoph
    Lang, Hauke
    Otto, Gerd
    Zimmermann, Tim
    Marquardt, Jens U.
    Galle, Peter R.
    Woerns, Marcus A.
    Schattenberg, Joern M.
    BMC CANCER, 2015, 15
  • [29] Characteristics of contemporary drug clinical trials regarding the treatment of non-alcoholic steatohepatitis
    Zhao, Shanshan
    Zhang, Lan
    Zhao, Junzhe
    Kota, Vishnu Goutham
    Venkat, Kartik Mitra
    Tasnim, Farah
    Yu, Hanry
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (01)
  • [30] Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: Effects of statins and antidiabetic drugs
    Katsiki, Niki
    Athyros, Vasilios G.
    Mikhailidis, Dimitri P.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (03) : 521 - 522
12345